These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3481241)

  • 41. Chronic pancreatitis: clinical features and medical management.
    Bank S
    Am J Gastroenterol; 1986 Mar; 81(3):153-67. PubMed ID: 3513542
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9.
    Haglund C; Kuusela P; Jalanko H; Roberts PJ
    Int J Cancer; 1987 Apr; 39(4):477-81. PubMed ID: 3470260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer.
    Pasquali C; Sperti C; D'Andrea AA; Bonadimani B; Del Favero G; Petrin P; Pedrazzoli S
    Pancreas; 1987; 2(1):34-7. PubMed ID: 3472197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 2). CA 19-9].
    Hayashi S; Ogasawara M
    Nihon Rinsho; 1986 Aug; 44(8):1817-20. PubMed ID: 3465967
    [No Abstract]   [Full Text] [Related]  

  • 46. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
    Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
    Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating immune complexes in carcinoma of the pancreas.
    Mihas AA; Volanakis JE; Schrohenloher RE; Mihas TA
    Anticancer Res; 1981; 1(3):155-8. PubMed ID: 7342854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low frequency of associated liver cirrhosis in chronic alcoholic pancreatitis.
    Tanaka T
    Am J Gastroenterol; 1990 Feb; 85(2):213. PubMed ID: 2301344
    [No Abstract]   [Full Text] [Related]  

  • 49. Association of chronic alcoholic liver and pancreatic disease: a prospective study.
    Angelini G; Merigo F; Degani G; Camplani N; Bovo P; Fratta Pasini A; Cavallini G; Brocco G; Scuro LA
    Am J Gastroenterol; 1985 Dec; 80(12):998-1003. PubMed ID: 4073007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbohydrate antigen (CA 19.9) and malignant glucagonoma.
    Archambeaud-Mouveroux F; Cardinaud F; Venot J; Bernard P; Bonnetblanc JM
    N Engl J Med; 1986 Dec; 315(24):1555. PubMed ID: 3024003
    [No Abstract]   [Full Text] [Related]  

  • 51. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis.
    Chao YC; Wang LS; Hsieh TY; Chu CW; Chang FY; Chu HC
    Am J Gastroenterol; 2000 Oct; 95(10):2958-64. PubMed ID: 11051375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma.
    Sakahara H; Endo K; Nakajima K; Nakashima T; Koizumi M; Ohta H; Hidaka A; Kohno S; Nakano Y; Naito A
    Cancer; 1986 Apr; 57(7):1324-6. PubMed ID: 3456252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathogenesis and diagnosis of pancreatitis of alcoholic etiology].
    Blagovidov DF; Ganzha PF
    Sov Med; 1988; (6):49-55. PubMed ID: 3055338
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
    Yao CZ; Zeng XJ; Wang SZ
    Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
    [No Abstract]   [Full Text] [Related]  

  • 55. [Assay of CA 19-9 in cancer of the pancreas: preliminary results].
    Gosselin P; Besson P; Demaille MC; Sulman C
    LARC Med; 1984; 4(6):383. PubMed ID: 6590940
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience.
    Kennedy T; Preczewski L; Stocker SJ; Rao SM; Parsons WG; Wayne JD; Bell RH; Talamonti MS
    Am J Surg; 2006 Mar; 191(3):437-41. PubMed ID: 16490563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioactive rose bengal test in the differential diagnosis of jaundice.
    Olsson R; Bjurstam N
    Surg Gynecol Obstet; 1973 Feb; 136(2):273-4. PubMed ID: 4686773
    [No Abstract]   [Full Text] [Related]  

  • 60. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.